Imaging AI platform company HOPPR secured nearly $32 million in Series A funding to advance its infrastructure for building and deploying large-scale medical imaging AI models.
Key Details
- 1HOPPR, founded in 2019 and based in Chicago, focuses on AI infrastructure for medical imaging.
- 2The company announced nearly $32 million in Series A funding, led by Greycroft and Kivu Ventures.
- 3Its platform supports PACS vendors and software makers in developing clinical-grade AI applications.
- 4The new funds will accelerate platform development, expand foundation model capabilities, and grow the team.
- 5CEO Khan Siddiqui, MD, states the goal is to democratize access to high-performing, trustworthy imaging AI.
Why It Matters
This funding round enables HOPPR to scale its infrastructure, potentially accelerating the development and deployment of clinically robust AI tools in radiology. Broad access to such platforms could enhance diagnostic workflows, support radiologists, and improve patient care globally.
Source
Radiology Business
Related News
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.
•Radiology Business
FDA Approves SimBioSys AI Tool for Breast Cancer Risk via MRI
SimBioSys received FDA clearance for TumorSight Risk, an AI tool assessing breast cancer recurrence risk using MRI.
•Radiology Business
FDA Clears MRI2CT AI for 3D Bone Visualization from MRI
MRI2CT's NextMR receives FDA clearance to generate 3D bone images from standard spine MRIs, reducing reliance on CT scans.